FERRANTE, EMANUELE
FERRANTE, EMANUELE
Universita' degli Studi di MILANO
Exploring the Role of Skull Base Anatomy in Surgical Approach Selection and Endocrinological Outcomes in Craniopharyngiomas
2026 A. Tozzi, G. Fiore, E. Sala, G.A. Bertani, S. Borsa, I. Carnicelli, E. Ferrante, G. Platania, G. Mantovani, M. Locatelli
Clinical picture of early infancy PTH resistance syndromes: is it time to improve diagnostic criteria?
2026 G. Del Sindaco, J. Berkenou, A. Pagnano, C. Audrain, E. Ferrante, A. Rothenbuhler, A. Linglart, G. Mantovani
Clinical predictors of outcome in advanced adrenocortical carcinoma: a multicenter international ENSAT study
2026 A. Mangone, B. Altieri, E. Ferrante, I. Bancos, M. Luconi, B. Ziółkowska, A. Barač Nekić, R. Libe, F. Ceccato, J.F. H Pittaway, M. Laganà, G. Di Dalmazi, E. Peverelli, O. Kimpel, B. Bahrani Fard, L. Canu, A. Kotecka-Blicharz, D. Kastelan, L. Bouys, I. Tizianel, G. Bennett, M. P Schauer, Y. S Elhassan, M. Detomas, L. Zanatta, M. Sadiq, G. Mantovani, C.L. Ronchi
Neuropsychological profile in acromegaly: a single center cross sectional analysis and preliminary prospective long-term study
2026 G. Abete Fornara, A. Mangone, V. Lotito, G. Del Sindaco, A. Cremaschi, G. Carosi, R. Mungari, E. Ferrante, G.A. Bertani, G. Fiore, M. Locatelli, E. Sala, G. Mantovani
Challenges and unmet needs in diagnosing polyuria-polydipsia syndrome: National survey by the Italian Society of Endocrinology
2025 A.M. Berton, E. Ferrante, P. Razzore
Therapeutic potential of targeting the FLNA‐regulated Wee1 kinase in adrenocortical carcinomas
2025 E. Esposito, G. Marra, R. Catalano, S. Maioli, E. Nozza, A.M. Barbieri, C. Hantel, G. Di Dalmazi, S. Sigala, J. Geginat, E. Cassinotti, L. Baldari, S. Palmieri, A. Mangone, A. Berruti, E. Ferrante, G. Mantovani, E. Peverelli
Therapeutic potential of targeting the FLNA-regulated Wee1 kinase in adrenocortical carcinomas
2024 E. Esposito/, R. Catalano, E. Nozza, G. Marra, S. Maioli, G. Dimuro, A.M. Barbieri, H. Constanze, G. Didalmazi, J.E. Geginat, E. Cassinotti, L. Baldari, S. Palmieri, A. Mangone, E. Ferrante, G. Mantovani, E. Peverelli
Sphingosine kinase 1 inhibitor safingol as a new possible therapeutic strategy for adrenocortical carcinoma
2024 E. Nozza, R. Catalano, E. Esposito, S. Palmieri, B. Altieri, L. Landwehr, H. Constanze, S. Sigala, E. Ferrante, G. Mantovani, E. Peverelli
The Novel SSTR3 Agonist ITF2984 Exerts Antimitotic and Proapoptotic Effects in Human Non-Functioning Pituitary Neuroendocrine Tumor (NF-PitNET) Cells
2024 G. Di Muro, R. Catalano, D. Treppiedi, A.M. Barbieri, F. Mangili, G. Marra, S. Di Bari, E. Esposito, E. Nozza, A.G. Lania, E. Ferrante, M. Locatelli, D. Modena, C. Steinkuhler, E. Peverelli, G. Mantovani
Macro-FSH is a rare cause of inappropriately high FSH concentrations
2024 B. Mantovani, R. Indirli, V. Lanzi, I. Petria, M. Arosio, G. Mantovani, E. Somigliana, M. Vidali, F. Ceriotti, E. Ferrante
High Prevalence of Hypercalcitoninemia in a Large Cohort of Adult and Pediatric Patients With PTH Resistance Syndromes
2024 A. Cremaschi, G. DEL SINDACO, A. Pagnano, A. Dolci, J. Berkenou, A. Rothenbuhler, A. Contarino, E. Ferrante, M. Arosio, E. Giannetta, A. Linglart, G. Mantovani
IGF2R: a new player in the insulin-like growth factor 2 (IGF2) pathway sustaining adrenocortical carcinoma cells growth
2023 E. Nozza, R. Catalano, E. Esposito, A.M. Barbieri, G. Marra, D. Treppiedi, G. Di Muro, F. Mangili, H. Constanze, S. Sigala, S. Palmieri, S. Frigerio, E. Ferrante, M. Arosio, G. Mantovani, E. Peverelli
Predicting tumor consistency and extent of resection in non-functioning pituitary tumors
2023 G. Fiore, G.A. Bertani, G. Conte, E. Ferrante, L. Tariciotti, E. Kuhn, L. Runza, M. Pluderi, S. Borsa, M. Caroli, E. Sala, G. Platania, K. Kremenova, S. Ferrero, F.M. Triulzi, G. Mantovani, M. Locatelli
A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells
2023 G. Di Muro, F. Mangili, E. Esposito, A.M. Barbieri, R. Catalano, D. Treppiedi, G. Marra, E. Nozza, A.G.A. Lania, E. Ferrante, M. Locatelli, M. Arosio, E. Peverelli, G. Mantovani
Prognostic value of copeptin and mid-regional proadrenomedullin in COVID-19-hospitalized patients
2022 R. Indirli, A. Bandera, L. Valenti, F. Ceriotti, A. Di Modugno, M. Tettamanti, R. Gualtierotti, F. Peyvandi, N. Montano, F. Blasi, G. Costantino, V. Resi, E. Orsi, M. Arosio, G. Mantovani, E. Ferrante
La diagnostica del diabete insipido
2021 E. Ferrante
COVID-19 in Cushing disease: experience of a single tertiary centre in Lombardy
2021 A.L. Serban, E. Ferrante, G. Carosi, R. Indirli, M. Arosio, G. Mantovani
Genetic profiling of a cohort of Italian patients with ACTH-secreting pituitary tumors and characterization of a novel USP8 gene variant
2021 D. Treppiedi, A.M. Barbieri, G. Di Muro, G. Marra, F. Mangili, R. Catalano, E. Esposito, E. Ferrante, A.L. Serban, M. Locatelli, A.G. Lania, A. Spada, M. Arosio, E. Peverelli, G. Mantovani
Treatment of Acromegalic Osteopathy in Real-Life Clinical Practice: The BAAC (Bone Active drugs in ACromegaly) Study
2020 G. Mazziotti, C. Battista, F. Maffezzoni, S. Chiloiro, E. Ferrante, N. Prencipe, L. Grasso, F. Gatto, R. Olivetti, M. Arosio, M. Barale, A. Bianchi, M. Cellini, I. Chiodini, L. De Marinis, G. Del Sindaco, C. Di Somma, A. Ferlin, E. Ghigo, A. Giampietro, S. Grottoli, E. Lavezzi, G. Mantovani, E. Morenghi, R. Pivonello, T. Porcelli, M. Procopio, F. Pugliese, A. Scillitani, A.G. Lania
Determinants of outcome of transsphenoidal surgery for Cushing disease in a single-centre series
2020 A.L. Serban, G. Del Sindaco, E. Sala, G. Carosi, R. Indirli, G. Rodari, C. Giavoli, M. Locatelli, G. Carrabba, G. Bertani, G. Marfia, G. Mantovani, M. Arosio, E. Ferrante